NCT05641116

Brief Summary

Lyme borreliosis, commonly known as Lyme disease, has been clinically described for more than a century, but has been officially recognized for 40 years, with the detection of the Borrelia bacterium by W. Burgdorfer, in ticks of the Ixodes ricinus complex, identified a few years before.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2023Dec 2027

First Submitted

Initial submission to the registry

November 8, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

September 14, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

3.2 years

First QC Date

November 8, 2022

Last Update Submit

July 2, 2025

Conditions

Keywords

sedentary timetherapeutic education of the patientadapted physical activitytraining program

Outcome Measures

Primary Outcomes (1)

  • Average level of moderate to vigorous physical activity (PA) - MET-h/week

    MET = metabolic equivalent This is measured with actimetry (Actigraph GT3x, Pensacola, Florida, USA).

    1 year after implementation of the PA program

Secondary Outcomes (9)

  • average level of sedentary lifestyle (h/day)

    at Month 3, Month 6 and Month 12 after implementation of the PA program

  • Average level of moderate to vigorous physical activity (PA) - MET-h/week

    at Month 3, Month 6 and Month 12 after implementation of the PA program

  • Average level of sedentary lifestyle (h/day)

    at Month 3, Month 6 and Month 12 after implementation of the PA program

  • VO2max (in ml/min/kg)

    at Month 3, Month 6 and Month 12 after implementation of the PA program

  • Biceps muscular strength (kg)

    at Month 3, Month 6 and Month 12 after implementation of the PA program

  • +4 more secondary outcomes

Study Arms (2)

Lyme Borreliosis with physical activity program

EXPERIMENTAL

Referral of the patient to the sport-health center of his department by the investigating physician (in connection with the attending physician for the prescription of Adaptive Physical Activity): for 24 sessions of APA for 3 months at a rate of 2 sessions/week at the sport and health center + 9 sessions of Therapeutic Patient Education in telecare

Other: physical activity program

Lyme Borreliosis patients with physical activity at home

OTHER

routine clinical practice : encouragement by the attending physician to modify lifestyle habits with advice on resuming regular physical activity independently and combating sedentariness. At home, in autonomy for 3 months.

Other: Advice and recommendations of physical activity at home

Interventions

24 face-to-face APA sessions at the sport and health center for 3 months at a rate of 2 sessions per week near his home and 9 therapeutic patient education workshops for 3 months at a rate of 3 workshops per month (telecare).

Lyme Borreliosis with physical activity program

Advice and recommendations of physical activity at home (= current clinical practice in autonomy for 3 months).

Lyme Borreliosis patients with physical activity at home

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient referred to the reference center for tick-borne diseases by his attending physician
  • Duration of symptoms \>6 months
  • At the end of the initial assessment, the diagnosis of functional somatic disorders is retained after consensus between the physicians
  • Patient practicing less than 150 minutes of regular physical activity per week (WHO recommendations)

You may not qualify if:

  • Patients with cardiac or respiratory pathologies that contraindicate the practice of physical activity physical activity
  • Important comorbidities contraindicating the practice of physical activity: associated cardiac pathologies associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies respiratory pathologies (obstructive or severe restrictive respiratory insufficiency), disabling joint pathologies joint pathologies (gonarthrosis or coxarthrosis limiting training on a treadmill or on a high-intensity bicycle). intensity cycling).
  • Patients under guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Clermont-Ferrand

Clermont-Ferrand, 63000, France

NOT YET RECRUITING

Chu Saint Etienne

Saint-Etienne, 42055, France

RECRUITING

MeSH Terms

Conditions

Lyme DiseaseMotor ActivityLyme NeuroborreliosisSedentary Behavior

Interventions

Counseling

Condition Hierarchy (Ancestors)

Gram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsBorrelia InfectionsSpirochaetales InfectionsTick-Borne DiseasesVector Borne DiseasesBehaviorCentral Nervous System Bacterial InfectionsCentral Nervous System InfectionsCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • David HUPIN, MD

    CHU de Saint Etienne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elisabeth BOTELHO-NEVERS, MD-PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2022

First Posted

December 7, 2022

Study Start

September 14, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations